Generex Biotechnology Subsidiary NuGenerex Immuno-Oncology Sponsors Susan G. Komen More Than Pink Walk
March 10, 2020 10:07 ET
|
Generex Biotechnology Corporation
2020 Komen More Than Pink™ Walk Saturday March 14, 2020 in Orlando, Florida MIRAMAR, Fla., March 10, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce...
Generex Signs Contract with EpiVax to Develop Ii-Key Peptide Vaccines to Address the Coronavirus Pandemic
March 04, 2020 09:00 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., March 04, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the...
Generex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine Technology
March 02, 2020 12:50 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., March 02, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the...
Generex Biotechnology Appoints Independent Director S. Gail Eckhardt, MD to the NuGenerex Immuno-Oncology Board of Directors
March 02, 2020 09:30 ET
|
Generex Biotechnology Corporation
-Chair of the Department of Oncology at The University of Texas at Austin’s Dell Medical School -Director of the Livestrong Cancer Institutes MIRAMAR, Fla., March 02, 2020 (GLOBE NEWSWIRE) --...
Generex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines
February 27, 2020 11:20 ET
|
Generex Biotechnology Corporation
-- Terms approved to proceed with collaborative effort with international consortium MIRAMAR, Fla., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com)...
Generex Issues Clarification on Stock Dividends
February 26, 2020 08:00 ET
|
Generex Biotechnology Corporation
Dividends officially paid on Monday, February 24, 2020° Ex-Dividend Date does not apply to NuGenerex Immuno-Oncology shares MIRAMAR, Fla., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology...
Generex Congratulates their Shareholders as FINRA has Officially Posted the Approval of the Generex Corporate Action and Payment of the Generex and NuGenerex Immuno-Oncology Stock Dividends on Monday, February 24, 2020
February 24, 2020 09:21 ET
|
Generex Biotechnology Corporation
Dividends officially to be paid on Monday, February 24, 2020• Shareholders to receive 2 to 5 stock dividend of Generex Biotechnology shares plus an additional 2 to 5 stock dividend of NuGenerex...
Generex Biotechnology Announces Investor Conference Dial-In Details Addressing the Coronavirus Pandemic with Ii-Key Peptide Vaccines and Corporate Update Thursday February 13, 2020 at 11:00 AM EST
February 12, 2020 09:00 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced call-in details for the upcoming investor conference call on...
Generex Biotechnology Announces Corporate Update and Investor Conference Call: Addressing the Coronavirus Pandemic with Ii-Key Peptide Vaccines - Thursday February 13, 2020 at 11:00 AM EST
February 10, 2020 09:00 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that Joe Moscato, President & Chief Executive Officer and the...
Generex Declares NEW Dividend RECORD DATE: Monday, February 17, 2020
February 07, 2020 08:30 ET
|
Generex Biotechnology Corporation
PAY DATE: Monday, February 24, 2020EX DATE: Tuesday, February 25, 2020 MIRAMAR, Fla., Feb. 07, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex”)...